Form D · Biotechnology
VentiRx Pharmaceuticals Inc.
Seattle, WA · CIK 0001367762
Offering snapshot reported Sep 30, 2014 · SEC filing
- Reported sold
- $15M Offering amount: $15M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 22, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 30, 2014 | Initial | $15,000,000 | No comparison | 1 | SEC filing |
| Sep 23, 2014 | Amendment | $50,602,514 | $31,852,513vs Mar 8, 2012 | 9 | SEC filing |
| Mar 8, 2012 | Amendment | $18,750,001 | $6,250,000vs Jan 22, 2010 | 5 | SEC filing |
| Jan 22, 2010 | Initial | $12,500,001 | No comparison | 5 | SEC filing |
| Mar 22, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 27, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 15, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-225512
Source: Form D, filed Sep 30, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kathleen Fanning | Executive |
| Steven Gillis, Ph.D. | Director |
| Elliot Grossbard, M.D. | Director |
| Patrick Heron | Director |
| Robert M. Hershberg, M.D., Ph.D. | Director, Executive |
| Michael J. Kamdar | Director, Executive |
| Ron Laufer | Director |
| Maggie Flanagan Le Flore, Ph.D. | Director |
| Atul Saran | Director |
| Kent Snyder | Director |
| Nicole Vitullo | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1191 Second Ave. Suite 1105
Seattle, WA, 98101
Seattle, WA, 98101